These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 399234)

  • 1. Angiotensin II, aldosterone and arterial pressure: a quantitative approach. Arthur C. Corcoran Memorial Lecture.
    Brown JJ; Casals-Stenzel J; Cumming AM; Davies DL; Fraser R; Lever AF; Morton JJ; Semple PF; Tree M; Robertson JI
    Hypertension; 1979; 1(3):159-79. PubMed ID: 399234
    [No Abstract]   [Full Text] [Related]  

  • 2. Renal artery stenosis with normal angiotensin II values. Relationship between angiotensin II and body sodium and potassium on correction of hypertension by captopril and subsequent surgery.
    Atkinson AB; Brown JJ; Davies DL; Leckie B; Lever AF; Morton JJ; Robertson JI
    Hypertension; 1981; 3(1):53-8. PubMed ID: 7009427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence that the acute hypotensive effect of captopril in dogs is not wholly explained by a reduction of plasma angiotensin II and its direct vasoconstrictor effect.
    Tree M; Morton JJ
    Clin Sci (Lond); 1980 Dec; 59(6):451-6. PubMed ID: 7002436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of angiotensin converting enzyme inhibitor SQ 14,225 on the blood pressure, renin-angiotensin-aldosterone system and renal function in patients with malignant hypertension (author's transl)].
    Shionoiri H; Uneda S; Tochikubo O; Ohonishi T; Harada J; Sesoko S; Goto E; Fujishima S; Kaneko Y
    Nihon Jinzo Gakkai Shi; 1980 Jan; 22(1):13-22. PubMed ID: 6247528
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of angiotensin I converting enzyme inhibitor (SQ 14225) on control of aldosterone.
    Eguchi T; Saito I; Nakamura R; Yasui T; Saruta T
    Acta Endocrinol (Copenh); 1980 Jun; 94(2):213-20. PubMed ID: 6251687
    [No Abstract]   [Full Text] [Related]  

  • 6. Interruption of the renin-angiotensin system in hypertensive patients by captopril induces sustained reduction in aldosterone secretion, potassium retention and natruiresis.
    Atlas SA; Case DB; Sealey JE; Laragh JH; McKinstry DN
    Hypertension; 1979; 1(3):274-80. PubMed ID: 399239
    [No Abstract]   [Full Text] [Related]  

  • 7. The pathophysiology of renovascular hypertension.
    Robertson JI; Morton JJ; Tillman DM; Lever AF
    J Hypertens Suppl; 1986 Oct; 4(4):S95-103. PubMed ID: 3534187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overview of the role of angiotensin inhibitors in delineating the function of the renin-angiotensin system.
    McCaa RE
    Prog Biochem Pharmacol; 1980; 17():29-35. PubMed ID: 7010367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Captopril in clinical hypertension. Changes in components of renin-angiotensin system and in body composition in relation to fall in blood pressure with a note on measurement of angiotensin II during converting enzyme inhibition.
    Atkinson AB; Morton JJ; Brown JJ; Davies DL; Fraser R; Kelly P; Leckie B; Lever AF; Robertson JI
    Br Heart J; 1980 Sep; 44(3):290-6. PubMed ID: 7000102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of aging on the renin angiotensin system in patients with renovascular hypertension.
    Morishita R; Higaki J; Mikami H; Matsukawa N; Ogihara T
    Methods Find Exp Clin Pharmacol; 1992; 14(1):17-21. PubMed ID: 1619967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of infused captopril on blood pressure and the renin-angiotensin-aldosterone system in normal dogs subjected to varying sodium balance.
    Morton JJ; Tree M; Casals-Stenzel J
    Am J Cardiol; 1982 Apr; 49(6):1395-400. PubMed ID: 7041583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin II is a necessary component for the development of hypertension in the two kidney, one clip rat.
    DeForrest JM; Knappenberger RC; Antonaccio MJ; Ferrone RA; Creekmore JS
    Am J Cardiol; 1982 Apr; 49(6):1515-7. PubMed ID: 6280481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the renin-angiotensin-aldosterone system in the regulation of blood pressure.
    Barger AC
    Adv Nephrol Necker Hosp; 1980; 9():271-93. PubMed ID: 6250379
    [No Abstract]   [Full Text] [Related]  

  • 14. Vasoactive peptides and hypertension: role of angiotensin converting enzyme.
    Johnston CI; Iansek R; Millar JA; McGrath BP; Matthews PG
    Aust N Z J Med; 1981; 11(Suppl 1):59-63. PubMed ID: 6266379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of alacepril on renin-angiotensin-aldosterone system and kallikrein-kinin-prostaglandin system in experimental animals.
    Hosoki K; Takeyama K; Minato H; Fukuya F; Kawahara S; Kadokawa T
    Arzneimittelforschung; 1986; 36(1):77-83. PubMed ID: 3006712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of the blood pressure and renal hemodynamic effects of captopril.
    Hall JE; Granger JP
    Am J Cardiol; 1982 Apr; 49(6):1527-9. PubMed ID: 7041591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of prolonged and brief infusions of noradrenaline on arterial pressure and on the plasma concentrations of active renin, angiotensin II, aldosterone and potassium.
    Casals-Stenzel J; Tree M; Brown JJ; Fraser R; Lever AF; Millar JA; Morton JJ; Robertson JI; Reid JL; Hamilton C
    J Hypertens; 1983 Jun; 1(1):27-35. PubMed ID: 6397510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of captopril and enalapril on sodium excretion and blood pressure in sodium-deficient dogs.
    McCaa RE; Gillespie JB
    Fed Proc; 1984 Apr; 43(5):1336-41. PubMed ID: 6323226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms in human renovascular hypertension.
    Maslowski AH; Nicholls MG; Espiner EA; Ikram H; Bones PJ
    Hypertension; 1983; 5(4):597-602. PubMed ID: 6345365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relation of arterial pressure and plasma angiotensin II concentration. A change produced by prolonged infusion of angiotensin II in the conscious dog.
    Bean BL; Brown JJ; Casals-Stenzel J; Fraser R; Lever AF; Millar JA; Morton JJ; Petch B; Riegger AJ; Robertson JI; Tree M
    Circ Res; 1979 Apr; 44(4):452-8. PubMed ID: 428042
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.